Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?

被引：1
|
作者：
van der Wekken, Anthonie J. [1 ]
Kok, Klaas [2 ,3 ]
Groen, Harry J. M. [1 ]
机构：
[1] Univ Groningen, Dept Pulm Dis, Groningen, Netherlands
[2] Univ Groningen, Dept Genet, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
CRIZOTINIB; RESISTANCE; INHIBITOR;
D O I：
10.21037/jtd.2018.06.45
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S2130 / S2132
页数：3
相关论文
共 50 条
  • [1] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 75 - 82
  • [2] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    McKeage, Kate
    DRUGS, 2015, 75 (01) : 75 - 82
  • [3] Erratum to: Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 241 - 241
  • [4] Safety of alectinib for the treatment of metastatic ALK-rearranged non-small cell lung cancer
    Zhu, Viola
    Ou, S. H.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 509 - 514
  • [5] The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer
    Srinivasamaharaj, Srividya
    Salame, Bilal Khameze
    Rios-Perez, Jorge
    Kloecker, Goetz
    Perez, Cesar A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1227 - 1233
  • [6] Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer
    Ando, Chihiro
    Ichihara, Eiki
    Nishi, Tatsuya
    Morita, Ayako
    Hara, Naofumi
    Takada, Kenji
    Nakasuka, Takamasa
    Watanabe, Hiromi
    Kano, Hirohisa
    Nishii, Kazuya
    Makimoto, Go
    Kondo, Takumi
    Ninomiya, Kiichiro
    Fujii, Masanori
    Kubo, Toshio
    Ohashi, Kadoaki
    Matsuoka, Ken-ichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    CANCER SCIENCE, 2023, 114 (11) : 4343 - 4354
  • [7] Cardiac Toxicity of Crizotinib Therapy in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Zhang, Yan
    Wang, Yan
    Li, Junling
    Hao, Xuezhi
    Ma, Di
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S377
  • [8] New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer
    Laird Cameron
    Benjamin Solomon
    Current Treatment Options in Oncology, 2015, 16
  • [9] New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer
    Cameron, Laird
    Solomon, Benjamin
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (10)
  • [10] Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
    Gandhi, Leena
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (14) : 3737 - 3742
12345